Literature DB >> 24204618

Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice.

Louise Bennett1, Cindy Kersaitis, Stuart Lance Macaulay, Gerald Münch, Garry Niedermayer, Julie Nigro, Matthew Payne, Paul Sheean, Pascal Vallotton, Dimitrios Zabaras, Michael Bird.   

Abstract

Vitamin D deficiency is widespread, affecting over 30% of adult Australians, and increasing up to 80% for at-risk groups including the elderly (age>65). The role for Vitamin D in development of the central nervous system is supported by the association between Vitamin D deficiency and incidence of neurological and psychiatric disorders including Alzheimer's disease (AD). A reported positive relationship between Vitamin D status and cognitive performance suggests that restoring Vitamin D status might provide a cognitive benefit to those with Vitamin D deficiency. Mushrooms are a rich source of ergosterol, which can be converted to Vitamin D2 by treatment with UV light, presenting a new and convenient dietary source of Vitamin D2. We hypothesised that Vitamin D2-enriched mushrooms (VDM) could prevent the cognitive and pathological abnormalities associated with dementia. Two month old wild type (B6C3) and AD transgenic (APPSwe/PS1dE9) mice were fed a diet either deficient in Vitamin D2 or a diet which was supplemented with VDM, containing 1±0.2 µg/kg (∼54 IU/kg) vitamin D2, for 7 months. Effects of the dietary intervention on memory were assessed pre- and post-feeding. Brain sections were evaluated for amyloid β (Aβ) plaque loads and inflammation biomarkers using immuno-histochemical methods. Plasma vitamin D metabolites, Aβ40, Aβ42, calcium, protein and cholesterol were measured using biochemical assays. Compared with mice on the control diet, VDM-fed wild type and AD transgenic mice displayed improved learning and memory, had significantly reduced amyloid plaque load and glial fibrillary acidic protein, and elevated interleukin-10 in the brain. The results suggest that VDM might provide a dietary source of Vitamin D2 and other bioactives for preventing memory-impairment in dementia. This study supports the need for a randomised clinical trial to determine whether or not VDM consumption can benefit cognitive performance in the wider population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24204618      PMCID: PMC3799746          DOI: 10.1371/journal.pone.0076362

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  92 in total

1.  Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia.

Authors:  M Sawada; A Suzumura; H Hosoya; T Marunouchi; T Nagatsu
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

2.  Basic composition and amino acid contents of mushrooms cultivated in Finland.

Authors:  Pirjo Mattila; Pirjo Salo-Väänänen; Karoliina Könkö; Heikki Aro; Taina Jalava
Journal:  J Agric Food Chem       Date:  2002-10-23       Impact factor: 5.279

3.  A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons.

Authors:  Erdinç Dursun; Duygu Gezen-Ak; Selma Yilmazer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.

Authors:  Andrzej Slominski; Jordan Zjawiony; Jacobo Wortsman; Igor Semak; Jeremy Stewart; Alexander Pisarchik; Trevor Sweatman; Josep Marcos; Chuck Dunbar; Robert C Tuckey
Journal:  Eur J Biochem       Date:  2004-11

5.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

6.  Generation of potentially bioactive ergosterol-derived products following pulsed ultraviolet light exposure of mushrooms (Agaricus bisporus).

Authors:  Michael D Kalaras; Robert B Beelman; Michael F Holick; Ryan J Elias
Journal:  Food Chem       Date:  2012-05-07       Impact factor: 7.514

7.  Heat-stable components of wood ear mushroom, Auricularia polytricha (higher Basidiomycetes), inhibit in vitro activity of beta secretase (BACE1).

Authors:  Louise Bennett; Paul Sheean; Dimitrios Zabaras; Richard Head
Journal:  Int J Med Mushrooms       Date:  2013       Impact factor: 1.921

Review 8.  Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.

Authors:  Darryl W Eyles; Thomas H J Burne; John J McGrath
Journal:  Front Neuroendocrinol       Date:  2012-07-11       Impact factor: 8.606

9.  Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Abeta peptide.

Authors:  A H Tammer; G Coia; R Cappai; S Fuller; C L Masters; P Hudson; J R Underwood
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

10.  Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease.

Authors:  Jing Du; Bing Sun; Kui Chen; Lang Zhang; Shubo Liu; Qingquan Gu; Li Fan; Nanming Zhao; Zhao Wang
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more
  13 in total

1.  Dietary Intake is Positively Associated with Cognitive Function of a Chinese Older Adults Sample.

Authors:  K Sun; H Hu; C Yang; L Wang; Y Ai; X Dong; Y Shi; M Li; Q Yao; Y Zhang
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register.

Authors:  J Zugic Soares; R Pettersen; J Saltyte Benth; A B Knapskog; G Selbæk; N Bogdanovic
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 3.  Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.

Authors:  Michael Fenech
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

4.  Safety of vitamin D2 mushroom powder as a Novel food pursuant to Regulation (EU) 2015/2283 (NF 2019/1471).

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Katerina Gerazova-Efremova; Ruth Roldán-Torres; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2022-06-10

5.  Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs.

Authors:  Christopher Millington; Sandra Sonego; Niloo Karunaweera; Alejandra Rangel; Janice R Aldrich-Wright; Iain L Campbell; Erika Gyengesi; Gerald Münch
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

Review 6.  Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.

Authors:  Véréna Landel; Cédric Annweiler; Pascal Millet; Maria Morello; François Féron
Journal:  J Alzheimers Dis       Date:  2016-05-11       Impact factor: 4.472

7.  Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Maria Morello; Véréna Landel; Emmanuelle Lacassagne; Kevin Baranger; Cedric Annweiler; François Féron; Pascal Millet
Journal:  Mol Neurobiol       Date:  2018-01-09       Impact factor: 5.590

8.  Uridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying Mechanism.

Authors:  Chia-Wei Phan; Pamela David; Kah-Hui Wong; Murali Naidu; Vikineswary Sabaratnam
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

9.  Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Authors:  Véréna Landel; Pascal Millet; Kévin Baranger; Béatrice Loriod; François Féron
Journal:  Mol Neurodegener       Date:  2016-03-01       Impact factor: 14.195

10.  Studying the Specific Activity of the Amide Form of HLDF-6 Peptide using the Transgenic Model of Alzheimer's Disease.

Authors:  A P Bogachouk; Z I Storozheva; G B Telegin; A S Chernov; A T Proshin; V V Sherstnev; Yu A Zolotarev; V M Lipkin
Journal:  Acta Naturae       Date:  2017 Jul-Sep       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.